Fatty acid cox inhibitor derivatives and their uses
AssigneeCatabasis Pharmaceuticals, Inc.
InventorsJill C. Milne, Michael R. Jirousek, Jean E. Bemis, Chi B. Vu
Life of this patent
Estimating the term…
Abstract
The invention relates to fatty acid COX inhibitor derivatives; compositions comprising an effective amount of a fatty acid COX inhibitor derivative; and methods for treating or preventing a metabolic, autoimmune inflammatory, or neurodegenerative disorder comprising the administration of an effective amount of a fatty acid COX inhibitor derivative.
Claims28
1-11. (canceled)
A method of treating inflammation, swelling, stiffness, or joint pain associated with rheumatoid arthritis, osteoarthritis, juvenile arthritis, ankylosing spondylitis, tendinitis, bursitis, or acute gout, the method comprising administering to a patient in need thereof an effective amount of a compound of Formula I:
- or a pharmaceutically acceptable salt, enantiomer, or stereoisomer thereof;
- wherein
- Rn is
- W1 and W2 are each independently S, NH, or NR;
- each a, b, c and d is independently —H, -D, —CH3, —OCH3, —OCH2CH3, —C(O)OR, or benzyl, or two of a, b, c, and d can be taken together, along with the single carbon to which they are bound, to form a cycloalkyl or heterocycle;
- each n, o, p, and q is independently 0, 1 or 2;
- each L is independently null, —O—, —S—, —S(O)—, —S(O)2—, —S—S—, —(C1-C6alkyl)-, —(C3-C6 cycloalkyl)-, a heterocycle, a heteroaryl,
- wherein the representation of L is not limited directionally left to right as is depicted, rather either the left side or the right side of L can be bound to the W1 side of the compound of Formula I;
- R6 is independently —H, -D, —C1-C4 alkyl, -halogen, cyano, oxo, thiooxo, —OH, —C(O)C1-C4 alkyl, —O-aryl, —O-benzyl, —OC(O)C1-C4 alkyl, C2-C3 alkene, C2-C3 alkyne, —C(O)C1-C4 alkyl, —NH2, —NH(C1-C3 alkyl), —N(C1-C3 alkyl)2, —NH(C(O)C1-C3 alkyl), —N(C(O)C1-C3 alkyl)2, —SH, —S(C1-C3 alkyl), —S(O)C1-C3 alkyl, or —S(O)2C1-C3 alkyl;
- each g is independently 2, 3 or 4;
- each h is independently 1, 2, 3 or 4;
- m is 0, 1, 2, or 3;
- if m is more than 1, then L can be the same or different;
- m1 is 0, 1, 2 or 3;
- k is 0, 1, 2, or 3;
- z is 1, 2, or 3;
- each R3 is independently H or C1-C6 alkyl, or both R3 groups, when taken together with the nitrogen to which they are attached, can form a heterocycle;
- each R4 is independently e, H or straight or branched C1-C10 alkyl which can be optionally substituted with OH, NH2, CO2R, CONH2, phenyl, C6H4OH, imidazole or arginine;
- each e is independently H or any side chain of a naturally occurring amino acid;
- each Z is independently —H,
- each r is independently 2, 3, or 7;
- each s is independently 3, 5, or 6;
- each t is independently 0 or 1;
- each v is independently 1, 2, or 6;
- R1 and R2 are each independently hydrogen, deuterium, —C1-C4 alkyl, -halogen, —OH, —C(O)C1-C4 alkyl, —O-aryl, —O-benzyl, —OC(O)C1-C4 alkyl, C2-C3 alkene, C2-C3 alkyne, —C(O)C1-C4 alkyl, —NH2, —NH(C1-C3 alkyl), —N(C1-C3 alkyl)2, —NH(C(O)C1-C3 alkyl), —N(C(O)C1-C3 alkyl)2, —SH, —S(C1-C3 alkyl), —S(O)C1-C3 alkyl, —S(O)2C1-C3 alkyl;
- and
- each R is independently —H, —C1-C3 alkyl, or straight or branched C1-C4 alkyl optionally substituted with OH, or halogen.
A method of treating pain associated with a menstrual period, a migraine headache, or dental pain, the method comprising administering to a patient in need thereof an effective amount of a compound of Formula I:
- or a pharmaceutically acceptable salt, enantiomer, or stereoisomer thereof;
- wherein
- Rn is
- W1 and W2 are each independently S, NH, or NR;
- each a, b, c and d is independently —H, -D, —CH3, —OCH3, —OCH2CH3, —C(O)OR, or benzyl, or two of a, b, c, and d can be taken together, along with the single carbon to which they are bound, to form a cycloalkyl or heterocycle;
- each n, o, p, and q is independently 0, 1 or 2;
- each L is independently null, —O—, —S—, —S(O)—, —S(O)2—, —S—S—, —(C1-C6alkyl)-, —(C3-C6cycloalkyl)-, a heterocycle, a heteroaryl,
- wherein the representation of L is not limited directionally left to right as is depicted, rather either the left side or the right side of L can be bound to the W1 side of the compound of Formula I;
- R6 is independently —H, -D, —C1-C4 alkyl, -halogen, cyano, oxo, thiooxo, —OH, —C(O)C1-C4 alkyl, —O-aryl, —O-benzyl, —OC(O)C1-C4 alkyl, C2-C3 alkene, C2-C3 alkyne, —C(O)C1-C4 alkyl, —NH2, —NH(C1-C3 alkyl), —N(C1-C3 alkyl)2, —NH(C(O)C1-C3 alkyl), —N(C(O)C1-C3 alkyl)2, —SH, —S(C1-C3 alkyl), —S(O)C1-C3 alkyl, or —S(O)2C1-C3 alkyl;
- each g is independently 2, 3 or 4;
- each h is independently 1, 2, 3 or 4;
- m is 0, 1, 2, or 3;
- if m is more than 1, then L can be the same or different;
- m1 is 0, 1, 2 or 3;
- k is 0, 1, 2, or 3;
- z is 1, 2, or 3;
- each R3 is independently H or C1-C6 alkyl, or both R3 groups, when taken together with the nitrogen to which they are attached, can form a heterocycle;
- each R4 is independently e, H or straight or branched C1-C10 alkyl which can be optionally substituted with OH, NH2, CO2R, CONH2, phenyl, C6H4OH, imidazole or arginine;
- each e is independently H or any side chain of a naturally occurring amino acid;
- each Z is independently —H,
- each r is independently 2, 3, or 7;
- each s is independently 3, 5, or 6;
- each t is independently 0 or 1;
- each v is independently 1, 2, or 6;
- R1 and R2 are each independently hydrogen, deuterium, —C1-C4 alkyl, -halogen, —OH, —C(O)C1-C4 alkyl, —O-aryl, —O-benzyl, —OC(O)C1-C4 alkyl, C2-C3 alkene, C2-C3 alkyne, —C(O)C1-C4 alkyl, —NH2, —NH(C1-C3 alkyl), —N(C1-C3 alkyl)2, —NH(C(O)C1-C3 alkyl), —N(C(O)C1-C3 alkyl)2, —SH, —S(C1-C3 alkyl), —S(O)C1-C3 alkyl, —S(O)2C1-C3 alkyl;
- and
- each R is independently —H, —C1-C3 alkyl, or straight or branched C1-C4 alkyl optionally substituted with OH, or halogen.
Dependencies are inferred from the claim text.